Global Gamma Knife Market Segmentation, By Disease Indications (Vascular Disorders, Brain Metastasis, Ocular Diseases, Functional Disorders, Arteriovenous Malformation (AVM), Trigeminal Neuralgia, Movement Disorders, Cancer and Others), Anatomy (Head, Neck and Others), End User (Hospitals, Clinics and Ambulatory Service Centers), Range (High-End Gamma Knife, Medium Gamma Knife, and Low Gamma Knife) – Industry Trends and Forecast to 2031.
Gamma Knife Market Analysis
The gamma knife market is experiencing significant growth, driven by advancements in technology, increasing demand for minimally invasive treatments, and rising incidence of neurological disorders. These factors, combined with growing awareness and acceptance of gamma knife therapy, are contributing to the steady expansion of the market. Additionally, the development of new applications for gamma knife technology, such as the treatment of brain metastases and functional disorders, is further driving market growth. Furthermore, the increasing availability of gamma knife treatment centres worldwide is providing greater access to this innovative therapy, contributing to market expansion.
Gamma Knife Market Size
The global gamma knife market size was valued at USD 445.93 million in 2023 and is projected to reach USD 658.84 million by 2031, with a CAGR of 5.0% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Gamma Knife Market Trends
“Growing awareness through conferences and educational campaigns”
Growing awareness among healthcare professionals and patients about the benefits of gamma knife technology is significantly driving its adoption across medical practices. As more positive clinical outcomes and success stories emerge, showcasing the effectiveness of gamma knife treatments for conditions like brain tumours and vascular malformations, healthcare providers are increasingly motivated to integrate these advanced systems into their offerings. Additionally, targeted educational campaigns and specialized medical conferences are pivotal in spreading knowledge about the advantages of gamma knife technology. Such events often feature detailed presentations on clinical trials, technological innovations, and patient testimonials, which help demystify the technology and promote its use among practitioners and patients alike.
Report Scope and Gamma Knife Market Segmentation
|
Attributes
|
Gamma Knife Market Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Elekta (Sweden), Varian Medical Systems, Inc. (U.S.), Accuray Incorporated (U.S.), Vision RT Ltd. (UK), MASEP Medical Science & Technology Development (Shenzhen) Co (China), Nordion (Canada) Inc. (Canada), Brainlab AG (Germany), CQ Medical (U.S.), Ono Sokki Co. Ltd. (India) Panacea Medical Technologies Pvt. Ltd.(India) Akesis, Inc. (U.S.), Fortis Healthcare (India), Corewell Health (U.S.)
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Gamma Knife Market Definition
Gamma Knife is a specialized medical device used for the precise and non-invasive treatment of brain tumors, vascular malformations, and other neurological conditions. It employs a targeted array of gamma rays to deliver high doses of radiation to a specific area within the brain, effectively treating abnormal tissues while minimizing damage to surrounding healthy tissue. The device is known for its accuracy and effectiveness in treating conditions such as acoustic neuromas, pituitary tumors, and arteriovenous malformations, making it a valuable tool in stereotactic radiosurgery.
Gamma Knife Market Dynamics
Drivers
- The Rising Prevalence Of Brain Tumours
With approximately 308,102 new cases and 251,329 deaths from brain and central nervous system (CNS) tumours reported globally in 2020, the urgency for effective, non-invasive treatments such as Gamma Knife radiosurgery is increasingly critical. Gamma Knife technology offers a precise and targeted approach to treating these complex conditions, addressing the growing need for advanced therapeutic options that minimize the invasiveness of traditional surgical methods. Such significant demand driven by high incidence and mortality rates underscores the gamma knife's role as a crucial driver in the market, highlighting its importance in advancing non-invasive treatment solutions for neurological disorders.
- Supportive Government Initiatives
The National Cancer Institute (NCI) in the United States has allocated substantial funding to research projects aimed at creating novel cancer medicines, including radiosurgery technologies such as Gamma Knife. Furthermore, national health policies, such as the UK's National Health Service (NHS) funding for cutting-edge cancer therapies, encourage the use of modern technologies. Such policies and funding opportunities are designed to improve patient outcomes and advance the quality of care, contributing significantly to the increased use and market growth of gamma knife systems.
Opportunities
- Innovative Applications for Gamma Knife Radiosurgery
Innovative applications for gamma knife radiosurgery are significantly expanding market opportunities. For instance, recent studies have explored the use of gamma knife radiosurgery in treating refractory epilepsy, particularly in patients with focal seizures that do not respond to medication. According to a study, Gamma Knife Radiosurgery for Mesial Temporal Lobe Epilepsy published in the National Library of Medicine found that gamma knife radiosurgery resulted in seizure freedom or significant reduction in seizures for approximately 50% of patients with epilepsy, highlighting its potential as an effective treatment option. Additionally, research into using gamma knife for certain psychiatric disorders, such as obsessive-compulsive disorder (OCD), has shown promising results in reducing symptoms when traditional therapies are ineffective. Expanding these indications not only enhances treatment options for patients but also drives further growth and adoption of gamma knife technology in the market.
- Growing Adoption of Stereotactic Radiosurgery (SRS)
The growing adoption of stereotactic radiosurgery (SRS) is significantly boosting the gamma knife market as it becomes a preferred treatment for various brain conditions. Stereotactic radiosurgery (SRS) is valued for its non-invasive nature, offering an alternative to traditional surgical methods with minimal recovery time and exceptional precision. For instance, data from the American society for radiation oncology (ASTRO) indicates that SRS is increasingly used for treating brain metastases, with studies showing it to be as effective as whole-brain radiation therapy but with fewer side effects and a shorter recovery period. Shifting trends towards non-invasive, precise treatment options drives the demand for gamma knife systems, underscoring their critical role in modern neurosurgical care.
Restraints/Challenges
- Competition from Alternative Treatments
Competition from alternative treatments presents a significant challenge to the gamma knife market. Advances in radiosurgery techniques, such as cyberknife and linear accelerator-based stereotactic radiosurgery (SRS), offer competitive options for treating brain tumors and other conditions. For instance, the cyberknife system, developed by accuracy, uses image-guided robotic technology to deliver precise radiation therapy, which has been shown to achieve comparable or superior outcomes to gamma knife in certain cases. The growing adoption of such alternative technologies, which often offer enhanced flexibility and fewer constraints compared to gamma knife, underscores the competitive pressures faced by gamma knife systems and thus restricts the market growth.
- High Cost Limiting Market Expansion
High costs associated with gamma knife systems present a significant barrier, with initial purchase prices often reaching multi-million-dollar ranges. The financial burden is compounded by substantial ongoing maintenance and operational expenses, including specialized staff training and technical support. Such unbearable costs can be prohibitive for smaller or resource-constrained facilities, limiting their ability to invest in and adopt gamma knife systems advanced technology. Consequently, the high cost can restrict the widespread availability of gamma knife treatments and hinder the market's overall growth potential.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Gamma Knife Market Scope
The market is segmented on the basis of disease indications, anatomy, end-user and range. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Disease Indications
- Vascular Disorders
- Brain Metastasis
- Ocular Diseases
- Functional Disorders
- Arteriovenous Malformation (AVM)
- Trigeminal Neuralgia
- Movement Disorders
- Cancer
- Others
Anatomy
- Head
- Neck
- Others
End User
- Hospitals
- Clinics
- Ambulatory Service Centers
Range
- High-End Gamma Knife
- Medium Gamma Knife
- Low Gamma Knife
Gamma Knife Market Regional Analysis
The market is analyzed and market size insights and trends are provided by disease indications, anatomy, end-user and range.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to several key factors, including escalating healthcare costs which drive investment in advanced medical technologies, a robust focus on research and development related to diabetes management, and a continuous stream of technological advancements. Additionally, the presence of leading industry players and a well-established healthcare infrastructure contribute to North America's market leadership.
Asia-Pacific is projected to experience the fastest growth from 2024 to 2031, driven by a surge in strategic initiatives from major market players seeking to expand their presence in the region. Favourable government initiatives, such as supportive policies and incentives for healthcare innovation, further accelerate market growth. Additionally, increasing healthcare expenditure and rising awareness about diabetes management in rapidly developing economies contribute to the region's expanding market opportunities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Gamma Knife Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Gamma Knife Market Leaders Operating in the Market Are:
- Elekta (Sweden)
- Varian Medical Systems, Inc. (U.S.)
- Accuray Incorporated (U.S.)
- Vision RT Ltd. (UK)
- MASEP Medical Science & Technology Development (Shenzhen) Co. (China)
- Nordion (Canada) Inc. (Canada)
- Brainlab AG (Germany)
- CQ Medical (U.S.)
- Ono Sokki Co. Ltd. (India)
- Panacea Medical Technologies Pvt. Ltd. (India)
- Akesis, Inc. (U.S.)
- Fortis Healthcare (India)
- Corewell Health (U.S.)
Latest Developments in Gamma Knife Market
- In June 2024, Fortis Memorial Research Institute introduced the Gamma Knife Esprit, marking the debut of this Leksell Gamma Knife in South Asia. According to the hospital, this state-of-the-art technology represents a new era in non-surgical, high-precision treatment for brain tumors, significantly expanding therapeutic options for both malignant and benign brain tumors, as well as other brain abnormalities.
- In April 2024, the AdventHealth Neuroscience Institute became the first facility in Central Florida to use the Elekta Esprit Gamma Knife for treating brain patients. This cutting-edge stereotactic radiosurgery (SRS) system provides highly precise ablative radiation to targeted areas in the brain while minimizing exposure to surrounding healthy tissue.
SKU-